| Dr Peter Blackburn, MD | |
|
110 Conn Ter Ste 550, Lexington, KY 40508-3206 | |
| (859) 323-5867 | |
| Not Available |
| Full Name | Dr Peter Blackburn |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 27 Years |
| Location | 110 Conn Ter Ste 550, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336196815 | NPI | - | NPPES |
| 64030489 | Medicaid | KY |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kentucky Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Medical Services Foundation, Inc | 5698689909 | 806 |
| Kentucky Institute For Eye Health And Surgery | 6204818974 | 12 |
News Archive
A cellular protein called HDAC6, newly characterized as a gatekeeper of steroid biology in the brain, may provide a novel target for treating and preventing stress-linked disorders, such as depression and post-traumatic stress disorder (PTSD), according to research from the Perelman School of Medicine at the University of Pennsylvania.
"Nine global HIV/AIDS advocacy organizations sent a letter [.pdf] to President Obama Thursday asking him to rethink his fiscal year (FY) 2013 budget recommendation to slash $546 million in funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program," the Center for Global Health Policy's "Science Speaks" blog reports.
What, exactly, does "successful aging" mean? For more than a half century, researchers and gerontologists have argued whether successful aging is better defined subjectively or objectively (physical disease-related disability or mental decline). Answering this question is more than an academic exercise. As the first members of the famed "baby boom generation" reach age 65, understanding what it means to remain healthy and independent in later life could have an enormous impact on health care delivery and medical policy.
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
› Verified 2 days ago
| Entity Name | Kentucky Medical Services Foundation, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326091448 PECOS PAC ID: 5698689909 Enrollment ID: O20031119000300 |
News Archive
A cellular protein called HDAC6, newly characterized as a gatekeeper of steroid biology in the brain, may provide a novel target for treating and preventing stress-linked disorders, such as depression and post-traumatic stress disorder (PTSD), according to research from the Perelman School of Medicine at the University of Pennsylvania.
"Nine global HIV/AIDS advocacy organizations sent a letter [.pdf] to President Obama Thursday asking him to rethink his fiscal year (FY) 2013 budget recommendation to slash $546 million in funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program," the Center for Global Health Policy's "Science Speaks" blog reports.
What, exactly, does "successful aging" mean? For more than a half century, researchers and gerontologists have argued whether successful aging is better defined subjectively or objectively (physical disease-related disability or mental decline). Answering this question is more than an academic exercise. As the first members of the famed "baby boom generation" reach age 65, understanding what it means to remain healthy and independent in later life could have an enormous impact on health care delivery and medical policy.
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
› Verified 2 days ago
| Entity Name | Kentucky Institute For Eye Health & Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636470 PECOS PAC ID: 6204818974 Enrollment ID: O20040605000067 |
News Archive
A cellular protein called HDAC6, newly characterized as a gatekeeper of steroid biology in the brain, may provide a novel target for treating and preventing stress-linked disorders, such as depression and post-traumatic stress disorder (PTSD), according to research from the Perelman School of Medicine at the University of Pennsylvania.
"Nine global HIV/AIDS advocacy organizations sent a letter [.pdf] to President Obama Thursday asking him to rethink his fiscal year (FY) 2013 budget recommendation to slash $546 million in funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program," the Center for Global Health Policy's "Science Speaks" blog reports.
What, exactly, does "successful aging" mean? For more than a half century, researchers and gerontologists have argued whether successful aging is better defined subjectively or objectively (physical disease-related disability or mental decline). Answering this question is more than an academic exercise. As the first members of the famed "baby boom generation" reach age 65, understanding what it means to remain healthy and independent in later life could have an enormous impact on health care delivery and medical policy.
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Blackburn, MD 110 Conn Ter Ste 550, Lexington, KY 40508-3206 Ph: (859) 323-5867 | Dr Peter Blackburn, MD 110 Conn Ter Ste 550, Lexington, KY 40508-3206 Ph: (859) 323-5867 |
News Archive
A cellular protein called HDAC6, newly characterized as a gatekeeper of steroid biology in the brain, may provide a novel target for treating and preventing stress-linked disorders, such as depression and post-traumatic stress disorder (PTSD), according to research from the Perelman School of Medicine at the University of Pennsylvania.
"Nine global HIV/AIDS advocacy organizations sent a letter [.pdf] to President Obama Thursday asking him to rethink his fiscal year (FY) 2013 budget recommendation to slash $546 million in funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program," the Center for Global Health Policy's "Science Speaks" blog reports.
What, exactly, does "successful aging" mean? For more than a half century, researchers and gerontologists have argued whether successful aging is better defined subjectively or objectively (physical disease-related disability or mental decline). Answering this question is more than an academic exercise. As the first members of the famed "baby boom generation" reach age 65, understanding what it means to remain healthy and independent in later life could have an enormous impact on health care delivery and medical policy.
Enzon Pharmaceuticals, Inc. today announced the Investigational New Drug (IND) approval by the US Food and Drug Administration (FDA) and plan to commence enrollment into a Phase 1a/1b study shortly. The study will evaluate the safety and tolerability of EZN-4176, the company's novel androgen receptor (AR) mRNA antagonist, for the treatment of patients with castration-resistant prostate cancer (CRPC).
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
› Verified 2 days ago
David R. Kielar, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jon David Hammer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 120 N Eagle Creek Dr Ste 211, Lexington, KY 40509 Phone: 859-263-3030 Fax: 859-263-2491 | |
Dr. Peter John Timoney, MBBCH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-1122 | |
Mohamed Magdy Khodeiry, MD, MSC Ophthalmology Medicare: Medicare Enrolled Practice Location: 110 Conn Ter Ste 550, Lexington, KY 40508 Phone: 859-323-5867 Fax: 859-323-8510 | |
John C. Sparrow, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 100 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-258-5310 Fax: 859-258-5328 | |
Dr. Jitander Singh Dudee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2351 Huguenard Drive, Suite 100, Lexington, KY 40503 Phone: 859-278-9486 Fax: 888-500-3329 | |
Alexander James Cherry, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 849-323-5867 |